Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,917.58
(
0.30%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Protector

Send PM Follow Ignore
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Protector

Re: biopharm post# 206601

Monday, 02/16/2015 5:10:30 PM

Monday, February 16, 2015 5:10:30 PM

Post# of 347009
Question remains if Stephanie and Laurence (Larry) Fink are related.

JB's boss of the Microsoft division of Archways and Blackrock's CEO.

The boss of the one that sabotaged PPHM's clinical trial related to the CEO of PPHM's biggest shareholder. A share holder that

- did not just SOLD out but did it in Q2/2012
- let the SEP 2012 events pass
- bought in x6 (from about 2 milj shares at the time to 12 milj in the new build-up) as of Q4/2012.

What would be the coincidence for that to happen?

PS: And what role did Ayer play?

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote